Levitra (vardenafil)

Levitra is a new oral treatment for managing erectile dysfunction (ED). Similar to Viagra®, it is a PDE-5 inhibitor. Developed and marketed by Glaxo and Bayer, a pharmaceutical company that follows the guidelines of the World Health Organization, Levitra is reported to work faster than Viagra.


How Levitra works

Levitra works by helping to relax the blood vessels in the penis, allowing blood to flow into the penis causing an erection. The effects of Levitra last for four to five hours. (Levitra will not provide an erection spontaneously.)


Levitra prescribed

A round shaped orange pill, Levitra (vardenafil) belongs to a group of medicines called PDE5 inhibitors. The strengths range from 5mg, 10mg and 20mg. Physicians prescribe Levitra in 10 mg or 20 mg thirty minutes prior to sexual intercourse.

Side effects:

According to the studies, the most common adverse effects associated with Levitra were mild to moderate and included headache, flushing and rhinitis (nasal congestion), myalgia (muscle pain), dyspepsia (upset stomach following meals) and back pain. The incidence of side effects was minimized with lower doses.


Levitra Notifications:

For patients with current medical ailments, consult your physician about how Levitra may interact other medications you may be taking. Levitra is not a hormone, aphrodisiac, a permanent cure for erectile dysfunction or a safeguard against sexually transmitted diseases.


Clinical Trials for Levitra:

For 1-year, clinical trials of 1,020 men with erectile dysfunction were given Levitra. The average success rate in maintaining erections improved from to 82 percent from 14 percent with the 10 mg dose. Moreover, the men who took 20mg doses improved from to 86 percent from 16 percent.

The following findings were found in the Levitra clinical trial:

Men taking Levitra on average reported a satisfaction rate three times higher than men taking placebo for erection hardness.

Significant improvements were noted in intercourse satisfaction, orgasmic function and overall sexual experience in men taking Levitra compared with men taking placebo.

Significantly more men taking Levitra experienced an erection adequate for completion of successful intercourse as early as 16 minutes after dosing compared with men taking placebo.

Among men taking Levitra the average success rate in maintaining erections improved from 16 percent to 86 percent (5.4 times).

On average, men were successful more than eight out of 10 times in maintaining an erection